155 related articles for article (PubMed ID: 11294071)
21. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
[TBL] [Abstract][Full Text] [Related]
22. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult.
Greydanus DE; Pratt HD; Patel DR
Dis Mon; 2007 Feb; 53(2):70-131. PubMed ID: 17386306
[TBL] [Abstract][Full Text] [Related]
23. [Effects and mechanisms of psychotherapy in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults].
Philipsen A; van Elst LT; Lesch KP; Jans T; Warnke A
Psychother Psychosom Med Psychol; 2009; 59(3-4):132-40. PubMed ID: 19350473
[TBL] [Abstract][Full Text] [Related]
24. Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD.
Pearson DA; Santos CW; Roache JD; Casat CD; Loveland KA; Lachar D; Lane DM; Faria LP; Cleveland LA
J Am Acad Child Adolesc Psychiatry; 2003 Feb; 42(2):209-16. PubMed ID: 12544181
[TBL] [Abstract][Full Text] [Related]
25. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
Wagner KD
Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
[TBL] [Abstract][Full Text] [Related]
26. [Evidence based therapy of children and adolescents with attention deficit/hyperactivity hyperkinetic syndrome (ADHS)].
Döpfner M; Lehmkuhl G
Prax Kinderpsychol Kinderpsychiatr; 2002; 51(6):419-40. PubMed ID: 12235708
[TBL] [Abstract][Full Text] [Related]
27. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
28. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
[TBL] [Abstract][Full Text] [Related]
29. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder.
Arch Gen Psychiatry; 1999 Dec; 56(12):1088-96. PubMed ID: 10591284
[TBL] [Abstract][Full Text] [Related]
30. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.
Arch Gen Psychiatry; 1999 Dec; 56(12):1073-86. PubMed ID: 10591283
[TBL] [Abstract][Full Text] [Related]
31. The acceptability of interventions for attention-deficit hyperactivity disorder among elementary and middle school teachers.
Power TJ; Hess LE; Bennett DS
J Dev Behav Pediatr; 1995 Aug; 16(4):238-43. PubMed ID: 7593658
[TBL] [Abstract][Full Text] [Related]
32. Attention-deficit/hyperactivity disorder.
Shaywitz BA; Fletcher JM; Shaywitz SE
Adv Pediatr; 1997; 44():331-67. PubMed ID: 9265975
[TBL] [Abstract][Full Text] [Related]
33. Effects of methylphenidate and behavior modification on the social and academic behavior of children with disruptive behavior disorders: the moderating role of callous/unemotional traits.
Waschbusch DA; Carrey NJ; Willoughby MT; King S; Andrade BF
J Clin Child Adolesc Psychol; 2007; 36(4):629-44. PubMed ID: 18088220
[TBL] [Abstract][Full Text] [Related]
34. A conceptual model of child psychopathology: implications for understanding attention deficit hyperactivity disorder and treatment efficacy.
Rapport MD; Chung KM; Shore G; Isaacs P
J Clin Child Psychol; 2001 Mar; 30(1):48-58. PubMed ID: 11294077
[TBL] [Abstract][Full Text] [Related]
35. Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD.
Klein RG; Abikoff H; Hechtman L; Weiss G
J Am Acad Child Adolesc Psychiatry; 2004 Jul; 43(7):792-801. PubMed ID: 15213580
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
37. Psychosocial interventions in attention deficit hyperactivity disorder.
Antshel KM; Barkley R
Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):421-37, x. PubMed ID: 18295154
[TBL] [Abstract][Full Text] [Related]
38. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
[TBL] [Abstract][Full Text] [Related]
39. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
40. Adults with attention deficit hyperactivity disorder: assessment and treatment considerations.
Murphy K
Semin Speech Lang; 1996 Aug; 17(3):245-53; quiz 254. PubMed ID: 8912439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
